SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-014876
Filing Date
2024-04-04
Accepted
2024-04-04 16:08:39
Documents
13
Period of Report
2024-04-01
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K aadi-20240401.htm   iXBRL 8-K 23989
  Complete submission text file 0001628280-24-014876.txt   150102

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aadi-20240401.xsd EX-101.SCH 1892
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aadi-20240401_lab.xml EX-101.LAB 22548
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aadi-20240401_pre.xml EX-101.PRE 13040
16 EXTRACTED XBRL INSTANCE DOCUMENT aadi-20240401_htm.xml XML 2832
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 24823213
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)